<p>Fiege said it marks the beginning of a comprehensive logistical co-operation within the healthcare segment in the Netherlands between Fiege and Twente Group of Hospitals, i.e. Ziekenhuisgroep Twente.
If approved, maraviroc would be the first member of a new class of oral HIV medicines in more than a decade. Maraviroc is a CCR5 antagonist, for use
The approvable letter indicated that before the new drug application can be cleared the FDA must receive and analyze final safety and efficacy data from the recently completed
The agreement also includes potential payments of up to $55 million based on meeting certain profit targets and product development targets for Alliant’s products. The company expects to
Under the terms of the agreement, US-based biopharmaceutical company VGX will have exclusive worldwide rights to develop a number of DNA plasmids and constructs with potential for the
The study, which took place at five centers, consisted of 113 pediatric patients, with 59 patients receiving treatment with Cutivate and 54 patients receiving treatment with mid-strength steroid
The company conducted two phase III double-blind, placebo-controlled studies in which Huntingdon's patients were randomized to receive either placebo or 2 grams (1 gram twice daily) of miraxion
Lexicon said that LX1031 was found to be well-tolerated at all doses tested in the recently completed phase Ia trial. “The safety and pharmacokinetic profile exhibited by LX1031
Cambus Medical currently employs 25 people at the Spiddal operation. The company recently extended the plant at Baile an tSagairt industrial estate, tripling its production capacity while providing
Exelixis suspended new patient enrollment in the ongoing XL999 clinical trials in November 2006, after cardiovascular events were observed. The FDA subsequently placed the clinical program on partial
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.